LPL Financial’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,740
| Closed | -$19.9K | – | 4679 |
|
|
2023
Q1 | $19.9K | Hold |
10,740
| – | – | ﹤0.01% | 4380 |
|
|
2022
Q4 | $11.9K | Sell |
10,740
-14,375
| -57% | -$16K | ﹤0.01% | 4381 |
|
|
2022
Q3 | $59K | Sell |
25,115
-600
| -2% | -$1.41K | ﹤0.01% | 4178 |
|
|
2022
Q2 | $78K | Sell |
25,715
-13,997
| -35% | -$42.5K | ﹤0.01% | 4142 |
|
|
2022
Q1 | $270K | Buy |
39,712
+2,277
| +6% | +$15.5K | ﹤0.01% | 3631 |
|
|
2021
Q4 | $313K | Sell |
37,435
-250
| -0.7% | -$2.09K | ﹤0.01% | 3645 |
|
|
2021
Q3 | $280K | Buy |
37,685
+250
| +0.7% | +$1.86K | ﹤0.01% | 3689 |
|
|
2021
Q2 | $255K | Sell |
37,435
-2,050
| -5% | -$14K | ﹤0.01% | 3707 |
|
|
2021
Q1 | $406K | Sell |
39,485
-1,775
| -4% | -$18.3K | ﹤0.01% | 3195 |
|
|
2020
Q4 | $289K | Sell |
41,260
-1,275
| -3% | -$8.93K | ﹤0.01% | 3216 |
|
|
2020
Q3 | $347K | Sell |
42,535
-660
| -2% | -$5.38K | ﹤0.01% | 2775 |
|
|
2020
Q2 | $298K | Buy |
43,195
+465
| +1% | +$3.21K | ﹤0.01% | 2818 |
|
|
2020
Q1 | $203K | Buy |
42,730
+15,890
| +59% | +$75.5K | ﹤0.01% | 2790 |
|
|
2019
Q4 | $234K | Buy |
26,840
+4,045
| +18% | +$35.3K | ﹤0.01% | 2962 |
|
|
2019
Q3 | $76K | Buy |
+22,795
| New | +$76K | ﹤0.01% | 3165 |
|